# GSK inaugurates €30M fostemsavir plant in Parma, Italy

GSK inaugurated a new €30 million, 1,500 m² plant at its San Polo di Torrile site in Parma, Italy, for production and packaging of fostemsavir, an HIV drug for heavily treatment-experienced patients.

- Type: New facility
- Announced: 2018-10-12
- Where: San Polo di Torrile, Parma, Italy
- Value: $34.5M (30.0M EUR)
- Starts operating: 12 Oct 2018
- Status: completed
- Products: fostemsavir (HIV drug)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GlaxoSmithKline](https://endata.com/companies/5584.md)
- [ViiV Healthcare](https://endata.com/companies/35990.md) (partner)

## Sources

- [it.gsk.com](https://it.gsk.com/it-it/media/comunicati-stampa/hiv-da-parma-innovazione-industria-e-cure-per-i-pazienti-di-tutto-il-mondo/), 2018-12-10: "Inaugurato oggi un nuovo impianto di 1.500 m² nello stabilimento GSK di San Polo di Torrile a Parma."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.